P690 Comparative efficacy of vedolizumab and adalimumab as...

Journal of Crohn's and Colitis 2019 / 01 Vol. 13; Iss. Supplement

P690 Comparative efficacy of vedolizumab and adalimumab as second-line therapy in ulcerative colitis patients previously treated with infliximab

Favale, A, Onali, S, Caprioli, F, Pugliese, D, Armuzzi, A, Macaluso, F S, Orlando, A, Viola, A, Fries, W, Mocci, G, Chicco, F, Usai, P, Rispo, A, Castiglione, F, Calabrese, E, Biancone, L, Monteleone,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Language:
english
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjy222.814
Date:
January, 2019
File:
PDF, 92 KB
english, 2019
Conversion to is in progress
Conversion to is failed